Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Boucher

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Expert Opinion on Pharmacotherapy|August 5, 2015
Dalbavancin for the treatment of acute bacterial skin and skin structure infectionsSheena Ramdeen, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?Adam Weston, Helen W Boucher
Canadian Medical Association Journal|July 1, 1983
Safety of hepatitis B vaccineJ Furesz, D W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancyKatherine Johnson, Helen W Boucher
Open Forum Infectious Diseases|May 1, 2020
What's Hot in Clinical Infectious Diseases? 2019 IDWeek SummarySean Moss, Helen W Boucher
JAMA|February 14, 2013
Antibiotics for skin infections: new study design and a step toward shorter course therapyShira Doron, Helen W Boucher
Biologicals : Journal of the International Association of Biological Standardization|April 1, 1990
The potency of tissue-type plasminogen activator (TPA) determined with chromogen and clot-lysis assaysM Christodoulides, D W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2013
Early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time?Adam Weston, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Editorial commentary: the Department of Defense fights the battle against antimicrobial resistance: can the United States win the war?Shira Doron, Helen W Boucher
Current Opinion in Pulmonary Medicine|March 19, 2015
Targeting antimicrobial-resistant bacterial respiratory tract pathogens: it is time to 'get smart'Boeun Lee, Helen W Boucher
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Expert Opinion on Pharmacotherapy|August 5, 2015
Dalbavancin for the treatment of acute bacterial skin and skin structure infectionsSheena Ramdeen, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?Adam Weston, Helen W Boucher
Canadian Medical Association Journal|July 1, 1983
Safety of hepatitis B vaccineJ Furesz, D W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancyKatherine Johnson, Helen W Boucher
Open Forum Infectious Diseases|May 1, 2020
What's Hot in Clinical Infectious Diseases? 2019 IDWeek SummarySean Moss, Helen W Boucher
JAMA|February 14, 2013
Antibiotics for skin infections: new study design and a step toward shorter course therapyShira Doron, Helen W Boucher
Biologicals : Journal of the International Association of Biological Standardization|April 1, 1990
The potency of tissue-type plasminogen activator (TPA) determined with chromogen and clot-lysis assaysM Christodoulides, D W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2013
Early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time?Adam Weston, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Editorial commentary: the Department of Defense fights the battle against antimicrobial resistance: can the United States win the war?Shira Doron, Helen W Boucher
Current Opinion in Pulmonary Medicine|March 19, 2015
Targeting antimicrobial-resistant bacterial respiratory tract pathogens: it is time to 'get smart'Boeun Lee, Helen W Boucher
Pageof 18